Invention Grant
- Patent Title: Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
- Patent Title (中): 使用CB1受体的拮抗剂来制造可用于治疗肝脏疾病的组合物
-
Application No.: US10598736Application Date: 2005-03-08
-
Publication No.: US08236763B2Publication Date: 2012-08-07
- Inventor: Sophie Lotersztajn , Ariane Mallat , Pascale Grenard , Boris Julien , Jeanne Tran Van Nhieu
- Applicant: Sophie Lotersztajn , Ariane Mallat , Pascale Grenard , Boris Julien , Jeanne Tran Van Nhieu
- Applicant Address: FR Paris Cedex FR Paris
- Assignee: Inserm,Sanofi-Aventis
- Current Assignee: Inserm,Sanofi-Aventis
- Current Assignee Address: FR Paris Cedex FR Paris
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Priority: EP04290633 20040309
- International Application: PCT/EP2005/003285 WO 20050308
- International Announcement: WO2005/084652 WO 20050915
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The invention relates to the use of antagonists to the CB1 receptor for the preparation of a composition for the treatment of hepatic diseases and preferably to the use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide.
Public/Granted literature
Information query
IPC分类:
